Alpha cognition inc. reports fourth quarter and full year 2024 financial results and operating overview

Vancouver, british columbia--(business wire)--alpha cognition inc. (nasdaq: acog) (“alpha cognition”, or the “company”) today announced its financial results for the fourth quarter and full year ended december 31, 2024. “we closed 2024 on a strong note, securing capital to support the zunveyl commercial launch and assembling an experienced leadership team,” said michael mcfadden, chief executive officer. “in early 2025, we completed the manufacturing of the initial commercial supply of zunveyl.
ACOG Ratings Summary
ACOG Quant Ranking